MedPlus Health Services Limited (BOM:543427)
808.85
+1.65 (0.20%)
At close: Jul 16, 2026
MedPlus Health Services Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, MedPlus Health Services stock has a consensus rating of "Strong Buy" and an average price target of ₹1,169. The average 1-year stock price forecast is 44.49% higher than the current stock price, while the lowest is ₹1,100 (+36.00%) and the highest is ₹1,271 (+57.14%).
Price Target: ₹1,169 (+44.49%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for MedPlus Health Services stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 7 |
Financial Forecast
Revenue This Year
78.65B
from 68.92B
Increased by 14.10%
Revenue Next Year
91.17B
from 78.65B
Increased by 15.93%
EPS This Year
21.67
from 18.29
Increased by 18.48%
EPS Next Year
25.54
from 21.67
Increased by 17.88%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.